Drugs / ToleroMune Grass
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01385800 | Aug 2011 → Jul 2013 | allergic rhinitis | Circassia Limited | Completed | No outcome recorded |
| Phase 2 | NCT01166061 | Jul 2010 → Apr 2011 | allergic disease | Circassia Limited | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ToleroMune Grass | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01166061 ↗ |
| Modality | Peptide | “synthetic, allergen-derived peptide desensitising vaccine” NCT01166061 ↗ |